Figure 5From: Decreased therapeutic effects of noscapine combined with imatinib mesylate on human glioblastoma in vitro and the effect of midkinecAMP levels. Nos, noscapine; IM, imatinib mesylate; Nos+IM, noscapine with imatinib mesylate. Results are mean of three different experiments and presented as mean ± SEM.Back to article page